5UR5

PYR1 bound to the rationally designed agonist 4m

Summary for 5UR5

• Entry DOI: 10.2210/pdb5ur5/pdb
• Related: 5UR4 5UR6
• Descriptor: Abscisic acid receptor PYR1, SULFATE ION, N-(4-cyano-3-ethyl-5-methylphenyl)-1-(4-methylphenyl)methanesulfonamide, ... (5 entities in total)
• Functional Keywords: pyr/pyl/rcar, pyr1, agonist, hormone receptor
• Biological source: Arabidopsis thaliana (Mouse-ear cress)
• Total number of polymer chains: 1
• Total formula weight: 22000.59

Authors

Peterson, F.C.,Vaidya, A.,Jensen, D.R.,Volkman, B.F.,Cutler, S.R. (deposition date: 2017-02-09, release date: 2017-11-29, Last modification date: 2023-10-04)

Primary citation

Vaidya, A.S.,Peterson, F.C.,Yarmolinsky, D.,Merilo, E.,Verstraeten, I.,Park, S.Y.,Elzinga, D.,Kaundal, A.,Helander, J.,Lozano-Juste, J.,Otani, M.,Wu, K.,Jensen, D.R.,Kollist, H.,Volkman, B.F.,Cutler, S.R.
A Rationally Designed Agonist Defines Subfamily IIIA Abscisic Acid Receptors As Critical Targets for Manipulating Transpiration.
ACS Chem. Biol., 12:2842-2848, 2017

PubMed Abstract: Increasing drought and diminishing freshwater supplies have stimulated interest in developing small molecules that can be used to control transpiration. Receptors for the plant hormone abscisic acid (ABA) have emerged as key targets for this application, because ABA controls the apertures of stomata, which in turn regulate transpiration. Here, we describe the rational design of cyanabactin, an ABA receptor agonist that preferentially activates Pyrabactin Resistance 1 (PYR1) with low nanomolar potency. A 1.63 Å X-ray crystallographic structure of cyanabactin in complex with PYR1 illustrates that cyanabactin's arylnitrile mimics ABA's cyclohexenone oxygen and engages the tryptophan lock, a key component required to stabilize activated receptors. Further, its sulfonamide and 4-methylbenzyl substructures mimic ABA's carboxylate and C6 methyl groups, respectively. Isothermal titration calorimetry measurements show that cyanabactin's compact structure provides ready access to high ligand efficiency on a relatively simple scaffold. Cyanabactin treatments reduce Arabidopsis whole-plant stomatal conductance and activate multiple ABA responses, demonstrating that its in vitro potency translates to ABA-like activity in vivo. Genetic analyses show that the effects of cyanabactin, and the previously identified agonist quinabactin, can be abolished by the genetic removal of PYR1 and PYL1, which form subclade A within the dimeric subfamily III receptors. Thus, cyanabactin is a potent and selective agonist with a wide spectrum of ABA-like activities that defines subfamily IIIA receptors as key target sites for manipulating transpiration.

PubMed: 28949512
DOI: 10.1021/acschembio.7b00650

Experimental method

X-RAY DIFFRACTION (1.93 Å)